Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
July 11, 2023
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
July 11, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
Moderna strikes deal to develop mRNA drugs in China
July 05, 2023
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
June 30, 2023
From CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
June 28, 2023
From CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
June 26, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
May 22, 2023
From CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
May 10, 2023
From CNBC.com News
From CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
April 28, 2023
From CNBC.com News
From CNBC.com News
Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices
April 21, 2023
From CNBC.com News
Senate legislation would cap insulin at $35 per month for people with private insurance
April 21, 2023
From CNBC.com News
Stocks making the biggest moves midday: Apple, Tesla, Netflix, Bed Bath & Beyond & more
April 13, 2023
From CNBC.com News
From CNBC.com News
Health misinformation is lowering U.S. life expectancy, FDA Commissioner Robert Califf says
April 11, 2023
From CNBC.com News
From CNBC.com News
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
March 16, 2023
From CNBC.com News
From CNBC.com News
Biden proposal to cap all insulin prices at $35 a month has little chance of passing Congress
February 09, 2023
From CNBC.com News
Trending billionaire and celebrity GLP-1 weight loss drugs are about to enter more American homes
January 20, 2023
From CNBC.com News
Cramer's lighting round: Stay away from Blackline
January 04, 2023
From CNBC.com News
Cramer's lighting round: I like Danaher over Philips
December 12, 2022
From CNBC.com News
From Business Journals
Stem cells may finally offer a cure for Type 1 diabetes
March 26, 2022
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.